Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Invested Capital (2016 - 2025)

Historic Invested Capital for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $1.3 billion.

  • Veracyte's Invested Capital rose 741.95% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 741.95%. This contributed to the annual value of $1.2 billion for FY2024, which is 1396.58% up from last year.
  • As of Q3 2025, Veracyte's Invested Capital stood at $1.3 billion, which was up 741.95% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Invested Capital peaked at $1.3 billion during Q3 2025, and registered a low of $972.1 million during Q2 2021.
  • In the last 5 years, Veracyte's Invested Capital had a median value of $1.1 billion in 2022 and averaged $1.1 billion.
  • As far as peak fluctuations go, Veracyte's Invested Capital skyrocketed by 32833.34% in 2021, and later crashed by 529.64% in 2022.
  • Over the past 5 years, Veracyte's Invested Capital (Quarter) stood at $1.1 billion in 2021, then dropped by 1.39% to $1.1 billion in 2022, then dropped by 3.19% to $1.0 billion in 2023, then rose by 13.97% to $1.2 billion in 2024, then increased by 6.56% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.